These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2977086

  • 1. Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia.
    Schwarcz R, Tamminga CA, Kurlan R, Shoulson I.
    Ann Neurol; 1988 Oct; 24(4):580-2. PubMed ID: 2977086
    [Abstract] [Full Text] [Related]

  • 2. Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome.
    Heyes MP, Rubinow D, Lane C, Markey SP.
    Ann Neurol; 1989 Aug; 26(2):275-7. PubMed ID: 2528321
    [Abstract] [Full Text] [Related]

  • 3. Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus-infected rhesus macaques: relationship to clinical and viral status.
    Heyes MP, Mefford IN, Quearry BJ, Dedhia M, Lackner A.
    Ann Neurol; 1990 Jun; 27(6):666-75. PubMed ID: 2163238
    [Abstract] [Full Text] [Related]

  • 4. Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease.
    Heyes MP, Swartz KJ, Markey SP, Beal MF.
    Neurosci Lett; 1991 Jan 28; 122(2):265-9. PubMed ID: 1827518
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased cerebrospinal fluid quinolinic acid, kynurenic acid, and L-kynurenine in acute septicemia.
    Heyes MP, Lackner A.
    J Neurochem; 1990 Jul 28; 55(1):338-41. PubMed ID: 2141357
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Free aminoacids concentration in the plasma, red cell hemolysates and cerebrospinal fluid of patients with Huntington's chorea (author's transl)].
    Bień A, Stepniewska E, Stepniewski M, Szafran Z.
    Przegl Lek; 1975 Jul 28; 32(11):796-802. PubMed ID: 129792
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease.
    Petersén A, Chase K, Puschban Z, DiFiglia M, Brundin P, Aronin N.
    Exp Neurol; 2002 May 28; 175(1):297-300. PubMed ID: 12009780
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA, Miranda AF, Tanguay JJ, Boegman RJ, Beninger RJ, Jhamandas K.
    Br J Pharmacol; 1998 May 28; 124(2):391-9. PubMed ID: 9641558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.